Keratinocyte Growth Factor-2 Production in an ompT-Deficient Escherichia coli K-12 Mutant
- 5 September 2008
- journal article
- research article
- Published by Wiley in Biotechnology Progress
- Vol. 20 (1) , 44-50
- https://doi.org/10.1021/bp0342147
Abstract
A variant form of Keratinocyte growth factor-2 (KGF-2) spanning amino acids A63-S208 was produced in the Escherichia coli K-12 host W3110. When the protein was purified using a standard process, the first six N-terminal amino acids were rapidly and specifically removed from the protein. This cleavage resulted in a truncated KGF-2 species (S69-S208). To circumvent this problem, guanidine-HCl was used to inhibit the putative proteolytic activity. This modified process resulted in a massive loss of protein product due to precipitation, in addition to the cost and corrosiveness of guanidine-HCl. To develop an economically feasible, scaleable, and robust process for KGF-2 production, we were tasked with identifying the protease(s) responsible for the N-terminal degradation. Experimental evidence revealed that OmpT (outer membrane protein T) was the primary protease involved in the N-terminal cleavage of the A63-S208 KGF-2 protein. Moreover, the OmpT-mediated cleavage occurred at a novel site (Arg-Ser). From this work, we show that production of the A63-S208 form of KGF-2 in an ompT-deleted E. coli host nearly abolished the N-terminal cleavage issue.Keywords
This publication has 36 references indexed in Scilit:
- Advances in Escherichia coli production of therapeutic proteinsCurrent Opinion in Biotechnology, 2001
- Recombinant protein expression in Escherichia coliPublished by Elsevier ,1999
- A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid LeukemiaBlood, 1997
- Inclusion bodies and purification of proteins in biologically active formsPublished by Springer Nature ,1997
- Commercial-Scale Refolding of Recombinant Methionyl Bovine SomatotropinPublished by American Chemical Society (ACS) ,1991
- Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous LeprosyNew England Journal of Medicine, 1986
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Direct expression in Escherichia coli of a DNA sequence coding for human growth hormoneNature, 1979
- Expression in Escherichia coli of chemically synthesized genes for human insulin.Proceedings of the National Academy of Sciences, 1979